RomReal Limited (OSL:ROM)
2.880
0.00 (0.00%)
At close: Aug 4, 2026
RomReal Revenue
RomReal had revenue of 170.00K EUR in the quarter ending March 31, 2026, with 165.63% growth. This brings the company's revenue in the last twelve months to 2.41M. In the year 2025, RomReal had annual revenue of 2.30M with 199.46% growth.
Revenue (ttm)
2.41M EUR
Revenue Growth
+199.46%
P/S Ratio
4.29
Revenue / Employee
219.00K EUR
Employees
11
Market Cap
116.17M NOK
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.30M | 1.53M | 199.46% |
| Dec 31, 2024 | 769.04K | 197.48K | 34.55% |
| Dec 31, 2023 | 571.56K | -4.28M | -88.22% |
| Dec 31, 2022 | 4.85M | 1.14M | 30.77% |
| Dec 31, 2021 | 3.71M | 2.07M | 126.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Techstep ASA | 971.65M |
| Skandia GreenPower AS | 693.28M |
| Voim ASA | 237.75M |
| Høland og Setskog Sparebank | 161.96M |
| Nidaros Sparebank | 144.56M |
| Barramundi Group | 102.71M |
| Observe Medical ASA | 18.81M |
| Norwegian Block Exchange AS | 18.46M |
RomReal News
- 2 months ago - RomReal Quarterly report: Q1 2026 - Filings
- 2 months ago - RomReal Slides: Q1 2026 - Filings
- 5 months ago - RomReal Quarterly report: Q4 2025 - Filings
- 5 months ago - RomReal Slides: Q4 2025 - Filings
- 5 months ago - RomReal Annual report: Q4 2025 - Filings
- 8 months ago - RomReal Quarterly report: Q3 2025 - Filings
- 8 months ago - RomReal Slides: Q3 2025 - Filings
- 1 year ago - RomReal Quarterly report: Q2 2025 - Filings